In my role as a cruise ship physician, I’ve come to understand the many factors that influence whether or not a passenger seeks medical care at sea. Trust, time, costs and uncertainty can all play a part in delaying medical assessment, even when symptoms warrant attention.
A recent case involving an elderly passenger demonstrated how quickly that decision can become more consequential.
Early symptoms, but limited concern
Prior to boarding, an 85-year-old male passenger reported a cough on his health declaration. As an epidemiological precaution, I checked his temperature and COVID-19 status. His temperature was normal at 36.6°C and his COVID-19 test came back negative, allowing him to proceed with embarkation.
The following day, he visited the medical centre because the cough had persisted. However, after learning that the consultation required a fee, he decided against being assessed and chose to monitor the symptoms himself.
Twenty-four hours later – approximately 48 hours after embarkation – he returned. By this point, he was experiencing a persistent cough, pain beneath both sides of his lower ribs and 12 hours of heartburn.
A significantly different clinical picture
His blood pressure, heart rate and temperature were within normal ranges at presentation, but his oxygen saturation was only 70% on room air. He appeared unwell and fatigued, with increased effort required to breathe.
His medical history included cardiomyopathy and a stent placed in the left anterior descending coronary artery approximately 30 years ago. He had no history of chronic obstructive pulmonary disease, asthma or diabetes.
Examination identified reduced chest expansion and decreased breath sounds on the right side, together with dullness on percussion over the lower right lung. Crackles and bronchial breath sounds were also present.
Blood tests showed a markedly elevated white blood cell count, while an ECG revealed T-wave inversion. A chest X-ray showed findings consistent with right basal pneumonia and vascular congestion, together with changes suggestive of bilateral bronchiectasis. The patient was diagnosed with pneumonia.
Stabilisation and disembarkation
Oxygen therapy began immediately, first through a mask, which he was unable to tolerate, and then via nasal cannula at six litres per minute. This increased his oxygen saturation to 85%, although it remained well below the normal range.
Further treatment included bronchodilators, intravenous and oral antibiotics, corticosteroids, a proton pump inhibitor, a diuretic and a mucolytic. Because he continued to desaturate to 70% without supplemental oxygen, he was admitted to the ship’s medical centre overnight for observation and continued treatment.
A shoreside referral was arranged for further assessment by an internal medicine team. We also requested an ambulance equipped with supplemental oxygen, allowing the patient to disembark safely the following morning.
Although we did not receive a formal report from the hospital, we were later informed by a group leader accompanying the passenger that he had been admitted to intensive care with pneumonia and that antibiotic treatment was continuing.
Supporting an informed decision
While it’s impossible to know how an earlier consultation would have affected this patient’s clinical course, the case illustrates the risk of delayed assessment in the face of persistent symptoms, particularly for an older passenger with a significant cardiac history.
Passengers should be informed of consultation fees before proceeding wherever circumstances allow. They should also understand the potential consequences of waiting. An undiagnosed condition can progress, potentially leading to more complex treatment, emergency disembarkation and considerably greater expense.
The role of the ship’s medical professional is not to pressure a passenger into receiving care. For an adult with decision-making capacity, that decision ultimately remains with the patient, but it should be informed by a clear explanation of the potential clinical and practical consequences of delay.
At sea, where further investigation and specialist care may be hours or days away, that conversation can itself be an important form of early intervention – even if the passenger ultimately declines a consultation.
Shareable Insights
- At sea, even a short delay in medical assessment can allow persistent symptoms to develop into a far more serious clinical situation.
- The immediate cost of a consultation must be considered alongside the potential clinical, operational and financial consequences of delayed care.
- Respecting patient choice means more than disclosing fees. It also requires a clear explanation of what could happen if assessment is postponed.
- When specialist care may be hours or days away, an informed conversation about the risks of delay can itself be an important early intervention.
